Academic Radiology
Volume 16, Issue 5 , Pages 627-637 , May 2009

Nanodelivery of MRI Contrast Agent Enhances Sensitivity of Detection of Lung Cancer Metastases

Received 13 November 2007 ,Accepted 15 December 2008.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 Supported in part by STTR Phase I grant 1R41 CA 121453-01 (E.H.C., M.F., K.F.P.), and a research grant from SynerGene Therapeutics (K.F.P.). These studies were conducted in part using the Histopathology and Tissue, and Animal Core Facilities supported by NCI Cancer Center Support grant and USPHS grant 2P30-CA-51008 and 1 S10 RR 15768-01. This investigation was conducted in part in a facility constructed with support from Research Facilities Improvement grant C06RR14567 from the National Center for Research Resources, National Institutes of Health, Bethesda, MD.

PII: S1076-6332(08)00742-3

doi: 10.1016/j.acra.2008.12.002

Academic Radiology
Volume 16, Issue 5 , Pages 627-637 , May 2009

Article Tools

* Image Usage & Resolution